These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23318460)

  • 41. Expression of the novel co-stimulatory molecule B7-H4 by renal tubular epithelial cells.
    Chen Y; Yang C; Xie Z; Zou L; Ruan Z; Zhang X; Tang Y; Fei L; Jia Z; Wu Y
    Kidney Int; 2006 Dec; 70(12):2092-9. PubMed ID: 17051145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.
    Maskey N; Li K; Hu M; Xu Z; Peng C; Yu F; Cao H; Chen J; Li Y; Yang G
    Tumour Biol; 2014 Dec; 35(12):11837-43. PubMed ID: 25260881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.
    Park GB; Song H; Kim YS; Sung M; Ryu JW; Lee HK; Cho DH; Kim D; Lee WJ; Hur DY
    Immunology; 2009 Nov; 128(3):360-8. PubMed ID: 20067536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
    Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8.
    Li A; Zhang N; Zhao Z; Chen Y; Zhang L
    Oncol Lett; 2020 Aug; 20(2):1535-1544. PubMed ID: 32724395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in Breast Cancer.
    El Din GS; Youness RA; Assal RA; Gad MZ
    Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis.
    Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
    Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
    Che F; Heng X; Zhang H; Su Q; Zhang B; Chen Y; Zhang Z; Du Y; Wang L
    Cancer Immunol Immunother; 2017 Jun; 66(6):717-729. PubMed ID: 28246881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B7-H4 downregulation induces mitochondrial dysfunction and enhances doxorubicin sensitivity via the cAMP/CREB/PGC1-α signaling pathway in HeLa cells.
    Kim HK; Song IS; Lee SY; Jeong SH; Lee SR; Heo HJ; Thu VT; Kim N; Ko KS; Rhee BD; Jeong DH; Kim YN; Han J
    Pflugers Arch; 2014 Dec; 466(12):2323-38. PubMed ID: 24658911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
    Leung J; St-Onge P; Stagg J; Suh WK
    Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
    Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
    Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown.
    Qian Y; Feng L; Wu W; Weng T; Hu C; Hong B; Wang FXC; Shen L; Wang Q; Jin X; Yao H
    Cell Physiol Biochem; 2017; 44(2):494-504. PubMed ID: 29145206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
    Kim NI; Park MH; Kweon SS; Lee JS
    Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation.
    Kumari G; Singhal PK; Suryaraja R; Mahalingam S
    J Mol Biol; 2010 Mar; 397(1):89-109. PubMed ID: 20064523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer.
    Zhu J; Chu BF; Yang YP; Zhang SL; Zhuang M; Lu WJ; Liu YB
    Asian Pac J Cancer Prev; 2013; 14(5):3011-5. PubMed ID: 23803071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth.
    Tian Y; Liu C; Li Z; Ai M; Wang B; Du K; Liu W; Wang H; Yu P; Chen C; Lin J; Xu A; Li R; Zhang W; Yuan Y
    Redox Biol; 2022 Oct; 56():102454. PubMed ID: 36044789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
    Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
    Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.